8:30 – 9:30 Andrea Blatt B.S., HAZMAT certified. Chemical Safety in the Laboratory. This presentation introduces the new GHS classification and labeling of chemicals. Formaldehyde safety and spill clean-up will also be reviewed.
9:45 – 10:45Ashley VarnerMSW, MBA, OSW-C. Oncology Social Work. This talk will cover the psychosocial issues common to people undergoing surgery for a possible cancer diagnosis including anxiety, depression, financial distress, and family strain. We will also cover issues of burn-out and compassion fatigue among providers and ways to avoid these complications.
11:00 – 12:00Ashley Allenby MGC, CGC.Genetics and Pathology of Hereditary Colorectal Cancer Syndromes. I will be discussing the connection between oncology genetic syndromes and GI pathology. Specifically, I will review Lynch syndrome and how universal tumor testing on all colorectal tumors informs germline genetic testing for the mismatch repair genes. I will also explain the differences between somatic genetic testing and germline genetic testing and the importance of clinical and family history when reviewing genetic test results.
I will describe various genetic syndromes that present with distinct GI pathology. This part of the presentation will include a detailed review of the cancer risks, genetics, inheritance pattern, and management recommendations for Peutz-Jeghers syndrome, juvenile polyposis syndrome, Cowden syndrome, mixed polyposis syndrome, familial adenomatous polyposis syndrome, Neurofibromatosis type 1, and MEN type 2. I will focus on highlighting important clinical information that may assist pathologists and pathology assistants with the classification of polyps.
The last part of my presentation will review several cases that demonstrate the importance of strong communication between genetics and pathology when establishing the differential and determining if genetic testing for a GI syndrome is warranted.
12:00 – 13:00 Lunch
13:00 – 13:15 Announcements
13:15 – 14:15 Holly Markel, PA (ASCP). GI Pathology. This presentation on GI pathology specimens will focus on total colectomies. The speaker will address updates on conditions associated with these specimens. Case studies and gross photographs will be used.
14:30 – 15:30 Carol Tweed, MD. Hematology/Oncology
1.Neoadjuvant therapies and significance of treatment response (i.e., what you see in pathology after our treatment and what therapeutic or prognostic implications it may have).
2. Genomic testing and relationship to adjuvant and metastatic decision making. what do we actually tell a patient in an exam room when those tests result? What leads us to order a certain test?
3. Immunotherapies approved and currently under investigation.
7:30 - 8:00 Breakfast
8:00 – 8:15 Intro
8:15 – 9:15 Tripp Holton, MD. Plastic and Reconstructive Surgery. What happens to the patient after the specimen hits the formalin? This presentation will focus on post-excisional surgical defect closure.
9:30 – 10:30 Lorraine Tafra, MD. Breast Surgery. Speaker will present an overview of the history of breast surgery and how it is changing. A discussion of lymph node management will be included.
10:45 – 11:45 Robert B Heaton, JR, MD. Breast Markers. The presentation will describe the clinically important aspects of breast markers with independent predictive value (ER/PR/Her2), from specimen handling through testing to treatment options and prognosis. The various testing methodologies (IHC, FISH) will be discussed.
11:45 – 12:45 Lunch
12:45 – 13:45 Kathryn Novicky, MS CT (ASCP). Cytology. Cytology, its roots; prior and current applications to pathology.
1400 – 1500 COMBO:
Emily M. Peterson, PA (ASCP). The Endoscopic Submucosal Dissection: Explanation of Procedure, Literature Review, and Discussion of Interesting Cases. Gastrointestinal tract cancer is one of the most common and most lethal forms of cancer worldwide. In Japan, Endoscopic Submucosal Dissection (ESD) is the standard of care for early gastric lesions with low risk of lymph node metastasis. In recent years, ESD has been catching-on in the United States where it is used to treat lesions of the esophagus, stomach, and large bowel. The procedure is intended for patients who are not candidates for major surgery due to advanced age or comorbidities. When performed by a skilled clinician, the procedure can be curative with low risk of complications.
This presentation will include a review of literature which will discuss adverse effects, long-term clinical outcomes, and future topics of research related to the ESD procedure. Additionally, this presentation will include histopathologic results from several ESD’s performed at Mercy Medical Center (Baltimore, MD) in which the procedure had an ablation effect on cancer cells.
Rocky Ackroyd PA (ASCP). Tattooing Colon Resections to Enhance Lymph Node Discovery. The presentation with introduce the concept of colonic tattooing to facilitate the discovery of regional lymph nodes at the time of dissection. The process enhances the discovery of additional lymph nodes including small nodes that are not easily discerned by palpation or visualization.
Hagen Schmitt PA (ASCP). The European Pathologists’ Assistant Equivalent. This presentation will be an overview of training and work environment of the German equivalent of a Pathologists’ Assistant in the US. Germany also has versions of the AAPA and ASCP: the VDP which will be discussed. Incite and comparison of the German, US, and English systems will be given.The speaker is a German trained Pathologists’ Assistant who has also worked as a PA in the UK, and has been a PA in the US for the past ten years.